GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs

Cephalalgia

Volumn 30, Issue 11, 2010, Pages 1366-1374

  Bernecker, Claudia ^a   Pailer, Sabine ^a   Kieslinger, Petra ^a   Horejsi, Renate ^a   Möller, Reinhard ^a   Lechner, Anita ^a   Wallner Blazek, Mirja ^a   Weiss, Sabine ^a   Fazekas, Franz ^a   Truschnig Wilders, Martini ^a   Gruber, Hans Jürgen ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

GLP 2; insulin; leptin; migraine

Indexed keywords

ADIPOCYTOKINE; GLUCAGON LIKE PEPTIDE 2; INSULIN; LEPTIN;

ADULT; ANTHROPOMETRY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MIGRAINE; RISK FACTOR;

ADULT; BODY MASS INDEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCAGON-LIKE PEPTIDE 2; HUMANS; HYPERINSULINISM; LEPTIN; MIGRAINE DISORDERS; RISK FACTORS;

EID: 79751498227     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410364674     Document Type: Article

References (51)

1. Bigal ME, Kurth T., Hu H., Santanello N., Lipton RB Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 2009 ; 72: 1864-1871.
2. Guldiken B., Guldiken S., Taskiran B., et al. Migraine in metabolic syndrome. Neurologist 2009 ; 15: 55-58.
3. Mattsson P. Migraine headache and obesity in women aged 40-74 years: a population-based study. Cephalalgia 2007 ; 27: 877-880. (Pubitemid 47125351)
4. Peterlin BL, Rosso AL, Rapoport AM, Scher AI Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 2010; 00: 1. (accessed 18 February 2010).
5. Winter AC, Berger K., Buring JE, Kurth T. Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia 2009 ; 29: 269-278.
6. Bigal ME, Liberman JN, Lipton RB Obesity and migraine: a population study. Neurology 2006 ; 66: 545-550. (Pubitemid 43739885)
7. Ford ES, Li C., Pearson WS, Zhao G., Strine TW, Mokdad AH Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 2008 ; 28: 1270-1276.
8. Keith SW, Wang C., Fontaine KR, Cowan CD, Allison DB BMI and headache among women: results from 11 epidemiologic datasets. Obesity (Silver Spring) 2008 ; 16: 377-383. (Pubitemid 351271919)
9. Bigal ME, Lipton RB Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006 ; 67: 252-257. (Pubitemid 44305408)
10. Peterlin BL, Alexander G., Tabby D., Reichenberger E. Oligomerization state-dependent elevations of adiponectin in chronic daily headache. Neurology 2008 ; 70: 1905-1911. (Pubitemid 351684644)
11. Scher AI, Stewart WF, Ricci JA, Lipton RB Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003 ; 106: 81-89. (Pubitemid 37329617)
12. Dunbar JC, Hu Y., Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997 ; 46: 2040-2043. (Pubitemid 27512093)
13. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997 ; 100: 270-278. (Pubitemid 27349073)
14. Peterlin BL, Bigal ME, Tepper SJ, Urakaze M., Sheftell FD, Rapoport AM Migraine and adiponectin: is there a connection? Cephalalgia 2007 ; 27: 435-446.
15. Shek EW, Brands MW, Hall JE Chronic leptin infusion increases arterial pressure. Hypertension 1998 ; 31: 409-414.
16. Cavestro C., Rosatello A., Micca G., et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache 2007 ; 47: 1436-1442. (Pubitemid 350209520)
17. Rainero I., Limone P., Ferrero M., et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 2005 ; 25: 593-597. (Pubitemid 41026024)
18. Berilgen MS, Bulut S., Gonen M., Tekatas A., Dag E., Mungen B. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia 2005 ; 25: 1048-1053. (Pubitemid 41532110)
19. Guldiken B., Guldiken S., Demir M., Turgut N., Tugrul A. Low leptin levels in migraine: a case control study. Headache 2008 ; 48: 1103-1107. (Pubitemid 351952085)
20. Peterlin BL The role of the adipocytokines adiponectin and leptin in migraine. J Am Osteopath Assoc 2009 ; 109: 314-317.
21. Festa A., Hanley AJ, Tracy RP, D'Agostino Jr R., Haffner SM Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 2003 ; 108: 1822-1830. (Pubitemid 37296091)
22. Lee JH, Chan JL, Yiannakouris N., et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003 ; 88: 4848-4856. (Pubitemid 37357535)
23. Rajala MW, Lin Y., Ranalletta M., et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 2002 ; 16: 1920-1930. (Pubitemid 34828098)
24. Silha JV, Krsek M., Skrha JV, Sucharda P., Nyomba BL, Murphy LJ Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003 ; 149: 331-335. (Pubitemid 37304704)
25. Haugen F., Drevon CA Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 2007 ; 148: 5478-5486. (Pubitemid 350012628)
26. Tsatsanis C., Zacharioudaki V., Androulidaki A., et al. Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun 2005 ; 335: 1254-1263. (Pubitemid 41215552)
27. Sheng CH, Di J., Jin Y., et al. Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 2008 ; 33: 135-143.
28. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005 ; 115: 911-919.
29. Qatanani M., Szwergold NR, Greaves DR, Ahima RS, Lazar MA Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest 2010 ; 00: 1. (accessed 18 February 2010 ).
30. Reilly MP, Lehrke M., Wolfe ML, Rohatgi A., Lazar MA, Rader DJ Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005 ; 111: 932-939. (Pubitemid 40279897)
31. Brubaker PL, Drucker DJ Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 2004 ; 145: 2653-2659. (Pubitemid 38686211)
32. Buteau J. GLP-1 receptor signaling: effects on pancreatic beta-cell proliferation and survival. Diabetes Metab 2008 ; 34 (Suppl 2). 73-77.
33. Drucker DJ Glucagon-like peptide 2. J Clin Endocrinol Metab 2001 ; 86: 1759-1764. (Pubitemid 32374934)
34. Frias JP, Edelman SV Incretins and their role in the management of diabetes. Curr Opin Endocrinol Diabetes Obes 2007 ; 14: 269-276. (Pubitemid 47067110)
35. Knauf C., Cani PD, Ait-Belgnaoui A., et al. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 2008 ; 149: 4768-4777.
36. Lim GE, Huang GJ, Flora N., LeRoith D., Rhodes CJ, Brubaker PL Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. Endocrinology 2009 ; 150: 580-591.
37. Holst JJ Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 1994 ; 107: 1848-1855. (Pubitemid 24357644)
38. Meier JJ, Nauck MA, Pott A., et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 2006 ; 130: 44-54. (Pubitemid 43049834)
39. International Headache Society. The International Classification of Headache Disorders. 2nd ed. Cephalalgia 2004 ; 24: 1-160.
40. Bic Z., Blix GG, Hopp HP, Leslie FM In search of the ideal treatment for migraine headache. Med Hypotheses 1998 ; 50: 1-7. (Pubitemid 28046394)
41. Kalish GM, Barrett-Connor E., Laughlin GA, Gulanski BI Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 2003 ; 88: 1646-1652. (Pubitemid 36623382)
42. Lin KC, Sagawa N., Yura S., Itoh H., Fujii S. Simultaneous increases of leptin and gonadotropin-releasing hormone following exogenous estrogen administration in women with normally menstrual cycle. Endocr J 2005 ; 52: 449-454. (Pubitemid 41380555)
43. Friedman JM, Halaas JL Leptin and the regulation of body weight in mammals. Nature 1998 ; 395: 763-770. (Pubitemid 28485436)
44. Gannage-Yared MH, Khalife S., Semaan M., Fares F., Jambart S., Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 2006 ; 155: 167-176. (Pubitemid 44103386)
45. Dyck DJ Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 2009 ; 34: 396-402.
46. Farooqi IS, O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009 ; 89 (Suppl): 980-984.
47. Clement K., Vaisse C., Lahlou N., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998 ; 392: 398-401. (Pubitemid 28168737)
48. Haluzik M., Haluzikova D. The role of resistin in obesity-induced insulin resistance. Curr Opin Investig Drugs 2006 ; 7: 306-311.
49. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999 ; 257: 79-83. (Pubitemid 29299050)
50. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000 ; 20: 1595-1599. (Pubitemid 30353893)
51. Drucker DJ Minireview: the glucagon-like peptides. Endocrinology 2001 ; 142: 521-527. (Pubitemid 32222398)